Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Welcomes Brian Riley as President and Chief Technical Officer, Joanne Lager, MD as Chief Medical Officer, and Adrian Chaisson as Chief of Staff.
By: Charlie Sternberg
Strengthens its global particle engineering capabilities.
The company is investing $90 million to expand two U.S. facilities to enhance capacity and efficiency.
By: Rachel Klemovitch
Villain offers extensive expertise in peptide and oligonucleotide development and manufacturing.
It is the only ready-to-use liquid immunoglobulin therapy with (IgA) content and is set for commercialization in 2026.
Partnership expected to improve yield and upgrade analytical methods ahead of clinical use and regulatory submissions.
Hervé Hoppenot will retire after 11 years of leading the company through major expansion.
Will develop and commercialize a potential treatment for obesity and metabolic disease based on technology licensed from the U.S. Department of Veterans Affairs.
Addressing increasing complexity, cost of drug development, and navigating regulatory compliance.
By: Kristin Brooks
This strategic partnership provides end-to-end visibility and best-in-class track and trace for Praxis’s customer base.
Mark Foster, General Manager of Oliver Design, shares insights on balancing patient needs, manufacturability, and sustainability in biopharma packaging.
As the pharmaceutical industry continues to evolve, so too does the role of secondary packaging.
Collaboration aims to commercialize a proposed biosimilar of dupilumab across Latin America.
Aim to accelerate the development and commercialization of a novel molecular glue degrader (MGD) program targeting cyclin-dependent kinase 2.
New collaboration aims to optimize a proprietary oral sustained-release dosage form of lenalidomide.
Claims that knock-off drugs sold by telehealth entities and compounding pharmacies are manufactured by foreign suppliers not authorized or inspected by the FDA.
Released By Upperton
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
